iSpeak Blog
Regulatory inspections place pharmaceutical quality and operations teams under intense scrutiny. Following the exit meeting, the issuance of observations triggers a demanding 15-day timeline (for US FDA Inspections) to deliver a complete and defensible response, frequently accompanied by significant stress, coordination challenges, and compliance risk.